Variant report

Variant	nsv520051
Chromosome Location	chr19:45660136-45664218
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:64)
CpG islands
(count:244)
Chromatin interactive
region (count:13)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:64 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BCL3	chr19:45661187-45661595	A549	lung:	n/a	n/a
2	BRCA1	chr19:45663273-45663318	HepG2	liver:	n/a	n/a
3	CHD2	chr19:45661514-45661525	Hela-S3	cervix:	n/a	n/a
4	CTCF	chr19:45661460-45661610	HepG2	liver:	n/a	n/a
5	CTCF	chr19:45660060-45660210	HepG2	liver:	n/a	n/a
6	FOXA1	chr19:45664205-45664376	T-47D	breast:	n/a	n/a
7	FOXP2	chr19:45664090-45664384	PFSK-1	brain:	n/a	n/a
8	MAX	chr19:45663986-45664652	ECC-1	luminal epithelium:	n/a	n/a
9	MAX	chr19:45664091-45664677	MCF-7	breast:	n/a	n/a
10	MAX	chr19:45664067-45664674	ECC-1	luminal epithelium:	n/a	n/a
11	MAX	chr19:45663971-45664689	MCF-7	breast:	n/a	n/a
12	MYC	chr19:45664130-45664482	MCF-7	breast:	n/a	n/a
13	MYC	chr19:45661141-45661243	H1-hESC	embryonic stem cell:	n/a	n/a
14	MYC	chr19:45661265-45661392	H1-hESC	embryonic stem cell:	n/a	n/a
15	MYC	chr19:45664106-45664393	MCF-7	breast:	n/a	n/a
16	NR2F2	chr19:45664113-45665215	MCF-7	breast:	n/a	n/a
17	POLR2A	chr19:45663260-45663270	H1-hESC	embryonic stem cell:	n/a	n/a
18	POLR2A	chr19:45663359-45663761	K562	blood:	n/a	n/a
19	POLR2A	chr19:45662074-45662080	HUVEC	blood vessel:	n/a	n/a
20	POLR2A	chr19:45664137-45664145	H1-hESC	embryonic stem cell:	n/a	n/a
21	POLR2A	chr19:45663039-45663217	K562	blood:	n/a	n/a
22	POLR2A	chr19:45663942-45664003	MCF-7	breast:	n/a	n/a
23	POLR2A	chr19:45659598-45660696	Hela-S3	cervix:	n/a	n/a
24	POLR2A	chr19:45660443-45660585	H1-hESC	embryonic stem cell:	n/a	n/a
25	POLR2A	chr19:45663213-45663286	K562	blood:	n/a	n/a
26	POLR2A	chr19:45662686-45663216	H1-hESC	embryonic stem cell:	n/a	n/a
27	POLR2A	chr19:45664053-45664067	H1-hESC	embryonic stem cell:	n/a	n/a
28	POLR2A	chr19:45664018-45664524	MCF-7	breast:	n/a	n/a
29	POLR2A	chr19:45661758-45661909	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr19:45661878-45661895	MCF-7	breast:	n/a	n/a
31	POLR2A	chr19:45662754-45662913	K562	blood:	n/a	n/a
32	POLR2A	chr19:45660387-45660389	MCF-7	breast:	n/a	n/a
33	POLR2A	chr19:45662927-45663021	MCF-7	breast:	n/a	n/a
34	POLR2A	chr19:45659786-45660745	MCF-7	breast:	n/a	n/a
35	POLR2A	chr19:45661385-45661866	MCF-7	breast:	n/a	n/a
36	POLR2A	chr19:45663325-45663358	K562	blood:	n/a	n/a
37	POLR2A	chr19:45662843-45663001	GM12878	blood:	n/a	n/a
38	POLR2A	chr19:45663953-45664318	GM12878	blood:	n/a	n/a
39	POLR2A	chr19:45664068-45664620	MCF-7	breast:	n/a	n/a
40	POLR2A	chr19:45660290-45660384	MCF-7	breast:	n/a	n/a
41	POLR2A	chr19:45661617-45661795	A549	lung:	n/a	n/a
42	POLR2A	chr19:45662326-45662648	K562	blood:	n/a	n/a
43	POLR2A	chr19:45663323-45663525	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr19:45660214-45660440	MCF-7	breast:	n/a	n/a
45	POLR2A	chr19:45660605-45660623	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr19:45663916-45663937	MCF-7	breast:	n/a	n/a
47	POLR2A	chr19:45664029-45664230	HepG2	liver:	n/a	n/a
48	POLR2A	chr19:45664117-45664556	ECC-1	luminal epithelium:	n/a	n/a
49	POLR2A	chr19:45663815-45663820	K562	blood:	n/a	n/a
50	POLR2A	chr19:45663200-45663202	K562	blood:	n/a	n/a

(count:244 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:45663415-45663465	HRPEpiC	eye:	n/a
2	chr19:45663472-45663522	SK-N-SH	brain:	n/a
3	chr19:45663527-45663577	SKMC	muscle:	n/a
4	chr19:45663472-45663522	ProgFib	skin:	n/a
5	chr19:45663415-45663465	HEK293	kidney:	embryo
6	chr19:45663415-45663465	GM12891	blood:	n/a
7	chr19:45663488-45663538	K562	blood:	n/a
8	chr19:45663488-45663538	LNCaP	prostate:	n/a
9	chr19:45663527-45663577	Caco-2	colon:	n/a
10	chr19:45663415-45663465	RPTEC	kidney:	n/a
11	chr19:45663488-45663538	HEK293	kidney:	embryo
12	chr19:45663527-45663577	HIPEpiC	eye:	n/a
13	chr19:45663472-45663522	NHDF-neo	bronchial:	n/a
14	chr19:45663527-45663577	NHBE	bronchial:	n/a
15	chr19:45663415-45663465	K562	blood:	n/a
16	chr19:45663472-45663522	K562	blood:	n/a
17	chr19:45663488-45663538	HEEpiC	esophagus:	n/a
18	chr19:45663527-45663577	T-47D	breast:	n/a
19	chr19:45663488-45663538	SAEC	small airway:	n/a
20	chr19:45663415-45663465	BE2_C	brain:	n/a
21	chr19:45663488-45663538	HPAEpiC	pulmonary alveolar:	n/a
22	chr19:45663488-45663538	HCF	heart:	n/a
23	chr19:45663415-45663465	SK-N-MC	brain:	n/a
24	chr19:45663415-45663465	HAEpiC	amniotic membrane:	n/a
25	chr19:45663472-45663522	AG04449	skin:	fetal
26	chr19:45663527-45663577	PANC-1	pancreas:	n/a
27	chr19:45663415-45663465	SK-N-SH	brain:	n/a
28	chr19:45663488-45663538	MCF10A-Er-Src	breast:	n/a
29	chr19:45663527-45663577	RPTEC	kidney:	n/a
30	chr19:45663488-45663538	SK-N-SH_RA	brain:	n/a
31	chr19:45663488-45663538	Jurkat	blood:	n/a
32	chr19:45663415-45663465	CMK	blood:	n/a
33	chr19:45663415-45663465	GM12892	blood:	n/a
34	chr19:45663527-45663577	HCM	heart:	n/a
35	chr19:45663488-45663538	HRCEpiC	kidney:	n/a
36	chr19:45663527-45663577	HPAEpiC	pulmonary alveolar:	n/a
37	chr19:45663488-45663538	ProgFib	skin:	n/a
38	chr19:45663527-45663577	NT2-D1	testis:	n/a
39	chr19:45663472-45663522	GM12891	blood:	n/a
40	chr19:45663488-45663538	HAEpiC	amniotic membrane:	n/a
41	chr19:45663488-45663538	NT2-D1	testis:	n/a
42	chr19:45663488-45663538	ovcar-3	ovarian:	n/a
43	chr19:45663527-45663577	HCF	heart:	n/a
44	chr19:45663488-45663538	T-47D	breast:	n/a
45	chr19:45663488-45663538	Caco-2	colon:	n/a
46	chr19:45663415-45663465	Hepatocyte	liver:	n/a
47	chr19:45663527-45663577	MCF-7	breast:	n/a
48	chr19:45663472-45663522	AG04450	lung:	fetal
49	chr19:45663472-45663522	HEK293	kidney:	embryo
50	chr19:45663527-45663577	SK-N-SH	brain:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr19:45658924..45660957-chr19:45717417..45719472,2	K562	blood:
2	chr19:45664088..45666150-chr19:45752306..45754556,2	K562	blood:
3	chr19:45576440..45580394-chr19:45659978..45661759,3	MCF-7	breast:
4	chr19:45664074..45668689-chr19:45680998..45684242,7	MCF-7	breast:
5	chr19:45659656..45660364-chr19:45671813..45672348,2	MCF-7	breast:
6	chr19:45658848..45663469-chr19:45680259..45684163,6	MCF-7	breast:
7	chr19:45662322..45663842-chr19:45681568..45683237,2	K562	blood:
8	chr19:45662769..45665493-chr19:45847031..45849570,2	MCF-7	breast:
9	chr19:45662322..45668242-chr19:45680645..45684470,7	K562	blood:
10	chr19:45659081..45661369-chr19:45681478..45683954,2	MCF-7	breast:
11	chr19:45663246..45665913-chr19:45689234..45691618,2	MCF-7	breast:
12	chr19:45663965..45672033-chr19:45672145..45675901,9	K562	blood:
13	chr19:45663488..45666150-chr19:45752160..45753806,2	K562	blood:

No data

Variant related genes	Relation type
NKPD1	TF binding region
NKPD1	CpG island
ENSG00000189114	chromatin interactions
ENSG00000266958	chromatin interactions
ENSG00000007255	chromatin interactions
ENSG00000104892	chromatin interactions
ENSG00000170684	chromatin interactions
ENSG00000007047	chromatin interactions
ENSG00000267545	chromatin interactions

Extended variants
information (count: 189 )
Associated
traits (count: 68 )

Variant overlapped rSNPs/rCNVs (count:189 , 50 per page) page: 1 2 3 4

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs10416371	chr19:45660136-45660137	Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
2	rs570653954	chr19:45660160-45660161	Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
3	rs187192151	chr19:45660171-45660172	Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
4	rs553036920	chr19:45660182-45660183	Bivalent Enhancer Weak transcription Flanking Active TSS Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
5	rs566417334	chr19:45660250-45660251	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
6	rs537747588	chr19:45660268-45660269	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
7	rs535448732	chr19:45660269-45660270	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
8	rs555051823	chr19:45660287-45660288	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
9	rs575560339	chr19:45660292-45660293	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
10	rs114809042	chr19:45660310-45660311	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
11	rs192068167	chr19:45660332-45660333	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
12	rs149228435	chr19:45660338-45660339	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
13	rs540423001	chr19:45660363-45660364	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
14	rs75893338	chr19:45660364-45660365	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
15	rs183230701	chr19:45660384-45660385	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
16	rs566323135	chr19:45660385-45660386	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
17	rs74333887	chr19:45660398-45660399	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
18	rs373996196	chr19:45660399-45660400	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
19	rs562870081	chr19:45660414-45660415	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
20	rs530869103	chr19:45660415-45660416	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
21	rs550905135	chr19:45660421-45660422	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
22	rs550047837	chr19:45660428-45660429	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
23	rs373585193	chr19:45660429-45660430	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
24	rs145219971	chr19:45660484-45660485	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
25	rs533185521	chr19:45660486-45660487	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
26	rs546444333	chr19:45660496-45660497	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
27	rs552425836	chr19:45660510-45660511	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
28	rs535178941	chr19:45660511-45660512	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
29	rs549010116	chr19:45660553-45660554	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
30	rs568502280	chr19:45660567-45660568	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
31	rs377701150	chr19:45660568-45660569	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
32	rs537407762	chr19:45660592-45660593	Weak transcription Bivalent Enhancer Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
33	rs558030091	chr19:45660626-45660627	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
34	rs10417602	chr19:45660639-45660640	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
35	rs534417534	chr19:45660650-45660651	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
36	rs554054360	chr19:45660680-45660681	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
37	rs574126979	chr19:45660688-45660689	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
38	rs542748864	chr19:45660712-45660713	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
39	rs562931040	chr19:45660720-45660721	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
40	rs137909744	chr19:45660727-45660728	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
41	rs142360044	chr19:45660728-45660729	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs76006823	chr19:45660733-45660734	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs76832325	chr19:45660734-45660735	Weak transcription Bivalent Enhancer Active TSS Enhancers	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs564388151	chr19:45660776-45660777	Weak transcription Bivalent Enhancer Active TSS Enhancers	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs533062331	chr19:45660802-45660803	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs553174439	chr19:45660830-45660831	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs372206057	chr19:45660878-45660879	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs546801416	chr19:45660889-45660890	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs560086164	chr19:45660966-45660967	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs1985440	chr19:45660972-45660973	Weak transcription Active TSS Enhancers Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:68)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Astrocytoma	22246337	CNVD
Ovarian cancer	22174824	CNVD
Ovarian cancer	20800559	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Spondylocostal dysostosis	21085971	CNVD
Nicotine metabolism	21956041	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Glioblastoma multiforme	17002787	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	16750200	CNVD
Colorectal cancer	20459617	CNVD
Adrenocortical carcinoma	18281524	CNVD
Prostate cancer	19156837	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Muscular dystrophy	17160897	CNVD
Multiple myeloma	16616336	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:97 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:45651800-45660200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
2	chr19:45654800-45660400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr19:45657600-45662000	Weak transcription	Primary hematopoietic stem cells	blood
4	chr19:45657800-45661400	Weak transcription	Breast Myoepithelial Primary Cells	Breast
5	chr19:45657800-45663800	Weak transcription	Gastric	stomach
6	chr19:45657800-45663800	Weak transcription	Pancreas	Pancrea
7	chr19:45657800-45668200	Weak transcription	Right Atrium	heart
8	chr19:45658000-45661200	Weak transcription	Spleen	Spleen
9	chr19:45658000-45662200	Weak transcription	HUVEC	blood vessel
10	chr19:45658800-45660800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
11	chr19:45659200-45660400	Enhancers	Placenta Amnion	Placenta Amnion
12	chr19:45659200-45663400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
13	chr19:45659400-45660200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
14	chr19:45659400-45660200	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
15	chr19:45659400-45661800	Enhancers	Esophagus	oesophagus
16	chr19:45659800-45660200	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
17	chr19:45659800-45660200	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
18	chr19:45659800-45660600	Enhancers	Rectal Mucosa Donor 31	rectum
19	chr19:45659800-45660600	Bivalent Enhancer	Stomach Mucosa	stomach
20	chr19:45659800-45660600	Flanking Bivalent TSS/Enh	HepG2	liver
21	chr19:45659800-45660600	Enhancers	NHEK	skin
22	chr19:45660000-45660200	Enhancers	A549	lung
23	chr19:45660000-45660600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr19:45660000-45660600	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
25	chr19:45660200-45660600	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
26	chr19:45660200-45660600	Bivalent Enhancer	Duodenum Mucosa	Duodenum
27	chr19:45660200-45661800	Active TSS	Foreskin Melanocyte Primary Cells skin01	Skin
28	chr19:45660200-45674000	Weak transcription	A549	lung
29	chr19:45660400-45663400	Weak transcription	Placenta Amnion	Placenta Amnion
30	chr19:45660600-45661800	Bivalent Enhancer	HepG2	liver
31	chr19:45661000-45664000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
32	chr19:45661200-45661800	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr19:45661200-45661800	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
34	chr19:45661200-45662000	Enhancers	Spleen	Spleen
35	chr19:45661400-45661600	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr19:45661400-45661800	Strong transcription	Breast Myoepithelial Primary Cells	Breast
37	chr19:45661400-45662000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
38	chr19:45661600-45661800	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
39	chr19:45661600-45662400	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr19:45661600-45662600	Enhancers	Primary hematopoietic stem cells short term culture	blood
41	chr19:45661600-45662600	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Male	--
42	chr19:45661800-45662000	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr19:45661800-45662000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr19:45661800-45662000	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
45	chr19:45661800-45662200	Bivalent/Poised TSS	Foreskin Melanocyte Primary Cells skin01	Skin
46	chr19:45661800-45662800	Weak transcription	Breast Myoepithelial Primary Cells	Breast
47	chr19:45661800-45662800	Weak transcription	Esophagus	oesophagus
48	chr19:45661800-45663000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
49	chr19:45662000-45662200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
50	chr19:45662000-45662400	Bivalent Enhancer	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links